News

Researchers at Keele University have published the first investigation into the variation in the chemical makeup of ...
Investigators compared early oncologic outcomes by staging modality among men diagnosed with very high-risk prostate cancer.
In patients with biochemical recurrence after prostate cancer surgery, the optimal duration of hormone therapy after salvage radiation therapy has been debated.
We recently published 10 Most Undervalued Pharma Stocks To Buy Now. Johnson & Johnson stands second among the most ...
Pedro C. Barata, MD, MSc, discusses the advantages and disadvantages of darolutamide in metastatic hormone-sensitive prostate cancer.
Research confirms that many men with nonmetastatic prostate cancer will not die of their disease once they received recommended treatment.
EEST Darolutamide receives EU approval in third indication for patients with advanced prostate cancer European Commission granted approval ...
The rising median age of people around the world has the same effect, since cancer can take decades to develop and therefore ...